Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated:  1/4/2016
UT Southwestern Medical Center
mi
from
Dallas, TX
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated: 1/4/2016
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated:  1/4/2016
Houston Methodist Hospital
mi
from
Houston, TX
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated: 1/4/2016
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated:  1/4/2016
UT Houston Memorial
mi
from
Houston, TX
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated: 1/4/2016
UT Houston Memorial
mi
from
Houston, TX
Click here to add this to my saved trials
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated:  1/4/2016
Scott & White Memorial Hospital
mi
from
Temple, TX
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated: 1/4/2016
Scott & White Memorial Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated:  1/4/2016
Intermountain Health Services
mi
from
Salt Lake City, UT
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated: 1/4/2016
Intermountain Health Services
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated:  1/4/2016
University of Virginia
mi
from
Charlottesville, VA
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated: 1/4/2016
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated:  1/4/2016
Swedish Health Services
mi
from
Seattle, WA
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated: 1/4/2016
Swedish Health Services
mi
from
Seattle, WA
Click here to add this to my saved trials
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated:  1/4/2016
Providence Health and Services - Washington
mi
from
Spokane, WA
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated: 1/4/2016
Providence Health and Services - Washington
mi
from
Spokane, WA
Click here to add this to my saved trials
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated:  1/4/2016
Charleston Area Medical Center
mi
from
Charleston, WV
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated: 1/4/2016
Charleston Area Medical Center
mi
from
Charleston, WV
Click here to add this to my saved trials
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated:  1/4/2016
Marshfield Clinic
mi
from
Marshfield, WI
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated: 1/4/2016
Marshfield Clinic
mi
from
Marshfield, WI
Click here to add this to my saved trials
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated:  1/4/2016
St. Luke's Medical Center
mi
from
Milwaukee, WI
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated: 1/4/2016
St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated:  1/4/2016
Governors of the University of Calgary and the Calgary Health Region
mi
from
Calgary,
Carotid Revascularization Endarterectomy Versus Stenting Trial
Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Status: Enrolling
Updated: 1/4/2016
Governors of the University of Calgary and the Calgary Health Region
mi
from
Calgary,
Click here to add this to my saved trials
Coordinating Center for Caregiver Intervention Trial
Coordinating Center for Multisite Intervention Trial for Diverse Caregivers
Status: Enrolling
Updated:  1/4/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Coordinating Center for Caregiver Intervention Trial
Coordinating Center for Multisite Intervention Trial for Diverse Caregivers
Status: Enrolling
Updated: 1/4/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Coordinating Center for Caregiver Intervention Trial
Coordinating Center for Multisite Intervention Trial for Diverse Caregivers
Status: Enrolling
Updated:  1/4/2016
Stanford University and Veterans Affairs
mi
from
Menlo Park, CA
Coordinating Center for Caregiver Intervention Trial
Coordinating Center for Multisite Intervention Trial for Diverse Caregivers
Status: Enrolling
Updated: 1/4/2016
Stanford University and Veterans Affairs
mi
from
Menlo Park, CA
Click here to add this to my saved trials
Coordinating Center for Caregiver Intervention Trial
Coordinating Center for Multisite Intervention Trial for Diverse Caregivers
Status: Enrolling
Updated:  1/4/2016
University of Miami at Miami, Center on Adult Development and Aging
mi
from
Miami, FL
Coordinating Center for Caregiver Intervention Trial
Coordinating Center for Multisite Intervention Trial for Diverse Caregivers
Status: Enrolling
Updated: 1/4/2016
University of Miami at Miami, Center on Adult Development and Aging
mi
from
Miami, FL
Click here to add this to my saved trials
Coordinating Center for Caregiver Intervention Trial
Coordinating Center for Multisite Intervention Trial for Diverse Caregivers
Status: Enrolling
Updated:  1/4/2016
Thomas Jefferson University at Philadelphia, Center for Applied Research on Aging and Health
mi
from
Philadelphia, PA
Coordinating Center for Caregiver Intervention Trial
Coordinating Center for Multisite Intervention Trial for Diverse Caregivers
Status: Enrolling
Updated: 1/4/2016
Thomas Jefferson University at Philadelphia, Center for Applied Research on Aging and Health
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Coordinating Center for Caregiver Intervention Trial
Coordinating Center for Multisite Intervention Trial for Diverse Caregivers
Status: Enrolling
Updated:  1/4/2016
University of Tennessee Health Science Center
mi
from
Memphis, TN
Coordinating Center for Caregiver Intervention Trial
Coordinating Center for Multisite Intervention Trial for Diverse Caregivers
Status: Enrolling
Updated: 1/4/2016
University of Tennessee Health Science Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
HOPE Research Institute
mi
from
Phoenix, AZ
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
HOPE Research Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Neurological Associates
mi
from
Fayetteville, AR
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Neurological Associates
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Alta Bates Summit Medical Center - Research and Education Institute
mi
from
Berkeley, CA
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Alta Bates Summit Medical Center - Research and Education Institute
mi
from
Berkeley, CA
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
USC, Keck School of Medicine Health Care Consultation Center
mi
from
Los Angeles, CA
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
USC, Keck School of Medicine Health Care Consultation Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
UC Davis
mi
from
Sacramento, CA
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
UC Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Yale University MS Center
mi
from
New Haven, CT
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Yale University MS Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Shepherd Center
mi
from
Atlanta, GA
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Shepherd Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Consultants in Neurology, Ltd.
mi
from
Northbrook, IL
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Consultants in Neurology, Ltd.
mi
from
Northbrook, IL
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Indiana University MS Center
mi
from
Indianapolis, IN
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Indiana University MS Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Associates in Neurology PSC
mi
from
Lexington, KY
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Associates in Neurology PSC
mi
from
Lexington, KY
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Maryland Center for MS
mi
from
Baltimore, MD
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Maryland Center for MS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Lahey Clinic
mi
from
Lexington, MA
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Lahey Clinic
mi
from
Lexington, MA
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
The Schapiro Center for MS
mi
from
Golden Valley, MN
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
The Schapiro Center for MS
mi
from
Golden Valley, MN
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Advanced Neurology Specialists
mi
from
Great Falls, MT
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Advanced Neurology Specialists
mi
from
Great Falls, MT
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
UMDNJ
mi
from
Newark, NJ
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
UMDNJ
mi
from
Newark, NJ
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Gimbel MS Center at Holy Name Hospital
mi
from
Teaneck, NJ
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Gimbel MS Center at Holy Name Hospital
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Jacobs Neurological Institute: Buffalo General Hospital
mi
from
Buffalo, NY
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Jacobs Neurological Institute: Buffalo General Hospital
mi
from
Buffalo, NY
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Corinne Goldsmith Dickinson Center for MS
mi
from
New York, NY
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Corinne Goldsmith Dickinson Center for MS
mi
from
New York, NY
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Columbia University Multiple Sclerosis Clinical Care Center
mi
from
New York, NY
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Columbia University Multiple Sclerosis Clinical Care Center
mi
from
New York, NY
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
University of Rochester
mi
from
Rochester, NY
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
SUNY Stony Brook
mi
from
Stony Brook, NY
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
SUNY Stony Brook
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
CMC - Neuroscience & Spine Institute, Division of Neurology
mi
from
Charlotte, NC
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
CMC - Neuroscience & Spine Institute, Division of Neurology
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Raleigh Neurology Associates
mi
from
Raleigh, NC
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Raleigh Neurology Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Wake Forest University, Dept of Neurology, M.S. Research
mi
from
Winston-Salem, NC
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Wake Forest University, Dept of Neurology, M.S. Research
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
The Center for Neurological Services
mi
from
Bismarck, ND
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
The Center for Neurological Services
mi
from
Bismarck, ND
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Ohio State University MS Center
mi
from
Columbus, OH
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Ohio State University MS Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Oregon Health & Science University, MS Center of Oregon, UHS-42
mi
from
Portland, OR
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Oregon Health & Science University, MS Center of Oregon, UHS-42
mi
from
Portland, OR
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Thomas Jefferson University Physicians
mi
from
Philadelphia, PA
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Thomas Jefferson University Physicians
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
The Neurological Research center, Inc
mi
from
Bennington, VT
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
The Neurological Research center, Inc
mi
from
Bennington, VT
Click here to add this to my saved trials
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  1/4/2016
Fletcher Allen Health Care
mi
from
Burlington, VT
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 1/4/2016
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials